相关实验视频
Updated: Sep 17, 2025

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.8K
全癌症副本数分析确定了针对个性化风险分层的优化大小值和并发模式
Minh P Nguyen1,2,3, William C Chen4,5,6, Kanish Mirchia1,2,3
1Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
Nature communications
|July 2, 2025
概括
癌症拷贝数变化 (CNA) 的大小各不相同,影响风险预测. 这项研究开发了使用CNA大小和共同发生的模型,以改善跨不同癌症的瘤控制和生存预测.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 生物信息学是一种生物信息学.
背景情况:
- 染色体不稳定,导致拷贝数变化 (CNAs),是癌症的一个关键特征.
- 目前用于CNA分析的方法缺乏标准化尺寸值,使临床应用复杂化.
- 对于CNA大小变化和同时发生的生物学和临床影响尚不清楚.
研究的目的:
- 开发癌症和染色体特定的模型,用于CNA大小和共发生.
- 使用这些模型来预测瘤控制和整体存活率.
- 改进各种癌症类型的风险分层策略.
主要方法:
- 对691个脑膜瘤和10383个瘤的CNA和临床数据的分析.
- 开发大小依赖的CNA和CNA并发模型.
- 用优化的尺寸值和同时发生模式验证预后CNA.
主要成果:
- 已建立的癌症和染色体特定模型用于CNA大小和同时发生.
- 确定了具有优化大小值和并发模式的预后CNA.
- 在不同类型的癌症中改善了风险分层.
结论:
- CNA的大小,焦点,数量和同时发生对于生物标志物的发展至关重要.
- 优化的CNA模型完善了针对侵略性瘤行为的个性化风险分层.
- 这些发现对开发用于癌症管理的新生物标志物有影响.
更多相关视频
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
11:02Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
19.5K
相关概念视频
Comparing Copy Number Variations and SNPs
18.0K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.0K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458